Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen

NCT01856257 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

71

Enrollment

NIH

Sponsor class

Stopped Safety: Stopping rule not met.

Conditions

Primary Renal Allograft Candidate
Kidney Transplantation

Interventions

BIOLOGICAL: Anti-thymocyte Globulin (Rabbit)
BIOLOGICAL: belatacept
DRUG: methylprednisolone
BIOLOGICAL: basiliximab
DRUG: mycophenolate mofetil
DRUG: tacrolimus

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]